• Latest Posts
ADVERTISEMENT

With $700 million Q3 rise, U.K. biotech spearheads European recovery

In Depth 16 Nov 2023

Meet the ‘biotech mafia’: how specialized biotech VC firms are dominating industry funding once again

In Depth 2 Oct 2023

PIPEs in biotech fundraising: is this growing trend fueled by economic uncertainty here to stay?

ADVERTISEMENT